We are excited to present the first volume of our Life Sciences Spotlight report, where we explore the latest trends, innovations, and breakthroughs shaping the future of life sciences. This report offers a comprehensive view of the dynamic landscape, covering: Policy Opportunities in 2025 Washington Recent Life Sciences Deal Trends 2024 Sampling of Representative Life Sciences Deals Living in a Post-Chevron World – Loper Bright and the Impact on FDA-Regulated Industries Are Medical Device Disputes the Latest “Smartphone Wars” at the ITC? Q&A with SxanPro Polsinelli Client is Saving Your Bananas Proposed Changes to Terminal Disclaimer Practice in Patent Applications Withdrawn after Industry Backlash Artificial Intelligence and Machine Learning Patenting Pitfalls in the Life Sciences Industry Q&A with Portal Innovations A Busy Biotech Week Boston Perspectives from the Host of The 10 Minute HealthBizCast

From family farms and businesses to established agribusinesses to emerging ag tech companies, a new federal law requires business entities to disclose their owners’ and control persons’ personal information, and for many entities, the time for disclosure is now.  Why this matters for you. From Wall Street to Main Street to your street, the vast majority of private and many nonprofit entities will be swept into Corporate Transparency Act (CTA) compliance. If you own or control a company, you need to pay attention. Not only is initial reporting important, but so is ongoing compliance and coordination with other information and disclosures you are currently making, and similar filings companies make on a regular basis. For corporations, limited liability companies and limited